Biodesix (BDSX) Preferred Stock Liabilities (2019 - 2020)
Biodesix (BDSX) reported Preferred Stock Liabilities of $194.0 million for Q3 2020, little changed on a YoY basis from $194.0 million in Q4 2019, and little changed quarter-over-quarter from $194.0 million in Q2 2020.
Biodesix (BDSX) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends
Biodesix has reported Preferred Stock Liabilities for 2 years, with the latest figure at $194.0 million in Q3 2020.
- For the quarter ending Q3 2020, Preferred Stock Liabilities changed 0.0% year-over-year to $194.0 million; the trailing twelve-month figure through Sep 2020 stood at $194.0 million (changed 0.0% YoY), and the FY2019 full-year result was $194.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q3 2020 stood at $194.0 million, roughly flat from $194.0 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $194.0 million in Q3 2019, with the low at $194.0 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | - |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | - |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | - |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | - |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | - |
| 10 | Biodesix | 146.77 Mn | 121.20 Mn | 21.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 193.96 Mn |
| Jun 30, 2020 | 193.96 Mn |
| Mar 31, 2020 | 193.96 Mn |
| Dec 31, 2019 | 193.96 Mn |
| Sep 30, 2019 | 193.96 Mn |